Skip to main content
. 2019 Nov 16;2019:3162063. doi: 10.1155/2019/3162063

Figure 1.

Figure 1

(a) The OPLS-DA model indicated a clear separation between the groups; (b) cross validation (R2 = 0.793 Q2 = 0.358); (c) metabolic hubs mainly affected in CAA patients.